Carcinoma in situ (230-234)

230 Carcinoma in situ of digestive organs
- 230.0 - Ca in situ oral cav/phar
- 230.1 - Ca in situ esophagus
- 230.2 - Ca in situ stomach
- 230.3 - Ca in situ colon
- 230.4 - Ca in situ rectum
- 230.5 - Ca in situ anal canal
- 230.6 - Ca in situ anus NOS
- 230.7 - Ca in situ bowel NEC/NOS
- 230.8 - Ca in situ liver/biliary
- 230.9 - Ca in situ GI NEC/NOS
231 Carcinoma in situ of respiratory system
- 231.0 - Ca in situ larynx
- 231.1 - Ca in situ trachea
- 231.2 - Ca in situ bronchus/lung
- 231.8 - Ca in situ resp sys NEC
- 231.9 - Ca in situ resp sys NOS
232 Carcinoma in situ of skin
- 232.0 - Ca in situ skin lip
- 232.1 - Ca in situ eyelid
- 232.2 - Ca in situ skin ear
- 232.3 - Ca in situ skin face NEC
- 232.4 - Ca in situ scalp
- 232.5 - Ca in situ skin trunk
- 232.6 - Ca in situ skin arm
- 232.7 - Ca in situ skin leg
- 232.8 - Ca in situ skin NEC
- 232.9 - Ca in situ skin NOS
233 Carcinoma in situ of breast and genitourinary system
- 233.0 - Ca in situ breast
- 233.1 - Ca in situ cervix uteri
- 233.2 - Ca in situ uterus NEC
- 233.30 - Ca in situ fem gen NOS
- 233.31 - Carcinoma in situ vagina
- 233.32 - Carcinoma in situ vulva
- 233.39 - Ca in situ fem gen NEC
- 233.4 - Ca in situ prostate
- 233.5 - Ca in situ penis
- 233.6 - Ca in situ male gen NEC
- 233.7 - Ca in situ bladder
- 233.9 - Ca in situ urinary NEC
234 Carcinoma in situ of other and unspecified sites
- 234.0 - Ca in situ eye
- 234.8 - Ca in situ NEC
- 234.9 - Ca in situ NOS